Examining Visceral Leishmaniasis/HIV Co-Infection In East Africa

In this post in the Global Network for Neglected Tropical Diseases’ (NTDs) “End the Neglect” blog, Julien Potet, NTD policy adviser at Medecins Sans Frontieres’ Campaign for Access to Essential Medicines, examines the treatment of visceral leishmaniasis among people living with HIV in East Africa. He writes, “With new and better treatment strategies being validated, it is time for East African countries where visceral leishmaniasis is endemic — mainly Sudan, South Sudan, Ethiopia and Kenya — to scale up their capacities for integrated diagnosis and treatment of HIV and visceral leishmaniasis” (12/8).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.